An Outbreak of ST80 Vancomycin-Resistant Enterococcus faecium in a Hospital in Guangzhou, China: Clinical and Genomic Epidemiology Study from 2022 to 2023
Microbial Drug Resistance · 01.09.2025 · 31 (9) · 269-278
DOI: 10.1177/10766294251361345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Drug Resistance, online erschienen am 25.08.2025. Verfasst von Yawen Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Enterococcus faecium, Gram-Positive Bacterial Infections, Vancomycin-Resistant Enterococci. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
A notable increase in the incidence of vancomycin-resistant Enterococcus faecium (VREfm) was observed at a hospital in Guangzhou, China, during 2022–2023. We conducted a retrospective cross-sectional study from January 1, 2022, to August 31, 2023, to investigate the clinical and genomic characteristics of VREfm. Clinical data were extracted from electronic medical records, and infection control measures were reviewed from the relevant department. VREfm confirmation was performed using antimicrobial susceptibility testing. Genomic characteristics were analyzed via the whole-genome sequencing. The prevalence of VREfm among E. faecium isolates rose significantly from 13.3% (10/75) in 2022 to 26.4% (40/151) by August 2023 ( p < 0.001). Concurrently, usage of third-generation cephalosporins increased by 8.4% (22.47 to 24.36 defined daily doses per 100 patient days), carbapenems by 34% (51.47–68.97), and vancomycin by 18% (21.15–24.97) (all p ≤ 0.001). Molecular analysis revealed ST80/CC17 (78%, 39/50) as the dominant clone, carrying vanA and virulence genes ( scm , acm, and fss3 ), suggesting clonal expansion of a lineage rarely reported in Guangzhou. Our study documented an outbreak of ST80/CC17 vanA -positive VREfm, characterized by virulence genes ( scm , acm, and fss3 ) and clonal dominance (78%, 39/50). The temporal association between reduced sodium hypochlorite disinfection (2.7-fold decline, p = 0.002), increased antibiotic selective pressure, and pathogen transmission highlights multifactorial drivers of this epidemic. These findings underscore the complex multifactorial nature of pathogen transmission, including the role of antibiotic use, infection control measures, and environmental factors in the spread of multidrug-resistant clones. Strengthened infection control strategies—integrating targeted disinfection, antibiotic stewardship, and genomic surveillance—are imperative to curb the spread of such multidrug-resistant clones.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Laboratory, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
- The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
- School of Medical Technology, Guangdong Medical University, Dongguan, China.
- Genskey Medical Technology Co., Ltd, Beijing, China.
Zitieren
APA
Deng, Y., Xie, X., Chen, B., Zhang, Z., Lan, J., Luan, Y., Rao, G., Han, P., & Duan, C. (2025). An Outbreak of ST80 Vancomycin-Resistant Enterococcus faecium in a Hospital in Guangzhou, China: Clinical and Genomic Epidemiology Study from 2022 to 2023. Microbial Drug Resistance, 31(9), 269-278. https://doi.org/10.1177/10766294251361345
Vancouver
Deng Y, Xie X, Chen B, Zhang Z, Lan J, Luan Y, et al. An Outbreak of ST80 Vancomycin-Resistant Enterococcus faecium in a Hospital in Guangzhou, China: Clinical and Genomic Epidemiology Study from 2022 to 2023. Microbial Drug Resistance. 2025;31(9):269-278. doi:10.1177/10766294251361345
BibTeX
@article{Deng2025,
author = {Deng, Yawen and Xie, Xiaoying and Chen, Baiji and Zhang, Zhixan and Lan, Jiaoni and Luan, Yi and Rao, Guanhua and Han, Peng and Duan, Chaohui},
title = {An Outbreak of ST80 Vancomycin-Resistant Enterococcus faecium in a Hospital in Guangzhou, China: Clinical and Genomic Epidemiology Study from 2022 to 2023},
journal = {Microbial Drug Resistance},
year = {2025},
volume = {31},
number = {9},
pages = {269--278},
doi = {10.1177/10766294251361345}
}
EUVIMED